Nöroendovasküler Girişimsel Tedavilerde Anti-trombotik İlaç Kullanımı

References (2)

1. D’Souza S. Aneurysmal Subarachnoid Hemorrhage. J Neurosurg Anesthesiol 2015; 27: 222-40. [CrossRef] Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40: 994-1025. [CrossRef] van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369: 306-18. [CrossRef] Suarez JI. Diagnosis and Management of Subarachnoid Hemorrhage. Continuum (Minneap Minn) 2015; 21: 1263-87. [CrossRef] Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 2016; 20: 277. [CrossRef] Millikan CH. Cerebral vasospasm and ruptured intracranial aneurysm. Arch Neurol 1975; 32: 433-49. [CrossRef] Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2011; 31: 1443-51. [CrossRef] Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998; 29: 251-6. [CrossRef] Keedy A. An overview of intracranial aneurysms. McGill J Med 2006; 9: 141-6.
2. Feigin VL, Rinkel GJE, Lawes CM, Algra A, Bennett DA, van Gijn J, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 2773-80. [CrossRef] Ruigrok YM, Buskens E, Rinkel GJE. Attributable risk of common and rare determinants of subarachnoid haemorrhage. Stroke 2001; 32: 1173-5. [CrossRef] Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives. Surg Neurol Int 2017; 8: 11. [CrossRef] Gieteling EW, Rinkel GJE. Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J Neurol 2003; 250: 418-23. [CrossRef] Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, et al. Medical complications of aneurysmal subarachnoid haemorrhage: a report of the multicentre, cooperative aneurysm study. Crit Care Med 1995; 23: 1007-17. [CrossRef] Rosenorn J, Eskesen V, Schmidt K, Ronde F. The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg 1987; 67: 329-32. [CrossRef] Ronkainen A